(Q48895143)

16 February 2018

title

Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist (English)

1 reference

16 February 2018

experimental autoimmune encephalomyelitis

main subject

1 reference

Zhi-Yin Lou

1

1 reference

16 February 2018

Chong-Bo Zhao

series ordinal

2

1 reference

16 February 2018

Bao-Guo Xiao

series ordinal

3

1 reference

16 February 2018

publication date

15 September 2011

1 reference

16 February 2018

Journal of Neuroscience Research

published in

1 reference

16 February 2018

volume

90

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

84-95

1 reference

16 February 2018

Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain

cites work

1 reference

Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol

21 January 2018

1 reference

The therapeutic potential of cannabis

21 January 2018

1 reference

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

21 January 2018

1 reference

Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

21 January 2018

1 reference

Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice

21 January 2018

1 reference

Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription

21 January 2018

1 reference

Cannabinoid-receptor expression in human leukocytes

21 January 2018

1 reference

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

21 January 2018

1 reference

Control of microglial neurotoxicity by the fractalkine receptor

21 January 2018

1 reference

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

21 January 2018

1 reference

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Role of cannabinoid receptors in inhibiting macrophage costimulatory activity

21 January 2018

1 reference

Therapeutic potential of cannabinoids in CNS disease

21 January 2018

1 reference

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

21 January 2018

1 reference

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

21 January 2018

1 reference

Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.

21 January 2018

1 reference

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands

21 January 2018

1 reference

Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus

21 January 2018

1 reference

Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats

21 January 2018

1 reference

Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells

21 January 2018

1 reference

The cannabinoid receptors.

21 January 2018

1 reference

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system

21 January 2018

1 reference

21 January 2018

Cannabis and the brain

1 reference

Cannabinoids and neuroprotection in CNS inflammatory disease

21 January 2018

1 reference

Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells.

21 January 2018

1 reference

Cannabinoids in multiple sclerosis: do they have a therapeutic role?

21 January 2018

1 reference

The cannabinoid system and immune modulation

21 January 2018

1 reference

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

21 January 2018

1 reference

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

21 January 2018

1 reference

The endocannabinoid system and its relevance for nutrition.

21 January 2018

1 reference

Cannabinoid receptors: where they are and what they do.

21 January 2018

1 reference

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

21 January 2018

1 reference

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

The seek of neuroprotection: introducing cannabinoids.

21 January 2018

1 reference

Presence and regulation of the endocannabinoid system in human dendritic cells

21 January 2018

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia

21 January 2018

1 reference

Endocannabinoids mediate neuron-astrocyte communication

21 January 2018

1 reference

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model

21 January 2018

1 reference

The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells

21 January 2018

1 reference

The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines

21 January 2018

1 reference

Pharmacology of cannabinoid CB1 and CB2 receptors.

21 January 2018

1 reference

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

21 January 2018

1 reference

The endocannabinoid system: physiology and pharmacology.

21 January 2018

1 reference

New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease

21 January 2018

1 reference

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage

21 January 2018

1 reference

New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids

21 January 2018

1 reference

CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.

21 January 2018

1 reference

Do cannabinoids reduce multiple sclerosis-related spasticity?

21 January 2018

1 reference

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

21 January 2018

1 reference

Cannabinoid receptors and their role in neuroprotection

21 January 2018

1 reference

Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade

21 January 2018

1 reference

Cannabinoids and neuroinflammation

21 January 2018

1 reference

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.22721

1 reference

16 February 2018

1 reference

16 February 2018